Please use this identifier to cite or link to this item:
http://hdl.handle.net/2445/113562| Title: | Somatostatin receptor-targeted organometallic iridium(III) complexes as novel theranostic agents |
| Author: | Novohradsky, Vojtech Zamora, Ana Gandioso, Albert Brabec, Viktor Ruiz, José Marchán Sancho, Vicente |
| Keywords: | Iridi Càncer Somatostatina Iridium Cancer Somatostatin |
| Issue Date: | 25-Apr-2017 |
| Publisher: | Royal Society of Chemistry |
| Abstract: | A novel somatostatin receptor-targeted anticancer agent based on the conjugation of a highly cytotoxic and luminiscent cyclometalated iridium(III) complex to tumor-targeting vectors based on octreotide peptide has been described, and its potential for targeted theranostic applications has been demonstrated. |
| Note: | Reproducció del document publicat a: https://doi.org/10.1039/c7cc01946g |
| It is part of: | Chemical Communications, 2017, vol. 53, p. 5523-5526 |
| URI: | http://hdl.handle.net/2445/113562 |
| Related resource: | https://doi.org/10.1039/c7cc01946g |
| ISSN: | 1359-7345 |
| Appears in Collections: | Articles publicats en revistes (Química Inorgànica i Orgànica) |
Files in This Item:
| File | Description | Size | Format | |
|---|---|---|---|---|
| 671086.pdf | 1.92 MB | Adobe PDF | View/Open |
This item is licensed under a
Creative Commons License
